Tousignant Jennifer

Insider profile

Tousignant Jennifer's trades of Viridian Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
424.27
Quantity 81,960 +40.8%
Value US$1,718,414
Transaction date
Proposed sale
Price
78.37
Quantity 91,394
Value US$3,585,327
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-20 2026-08-19 S Sale
81,960 +40.8%
424.27
US$1,718,414
81,960 +40.8% 424.27 US$1,718,414
2026-08-20 2026-08-19 PlS Planned sale
99,125 +4.1%
457.65
US$4,373,900
99,125 +4.1% 457.65 US$4,373,900
2026-08-19 2026-08-19 PrS Proposed sale
91,394
78.37
US$3,585,327
91,394 78.37 US$3,585,327
2026-03-04 2026-03-04 PrS Proposed sale
1,675
30.19
US$50,560
1,675 30.19 US$50,560
2026-01-02 2025-12-31 PlS Planned sale
2,272 -100.0%
31.16
US$70,796
2,272 -100.0% 31.16 US$70,796